| Popis: |
K+ channels are key modulators of neuronal excitability, and mutations in certain types of these channels are known to cause epileptic seizures. Activation of K+ channels is reported to suppress epileptic discharge; however, the types of K+-channel openers that are most effective as anti-epileptic agents are not well understood. We established a quantitative fluorescence assay using the Na+ indicator sodium-binding benzofuran isophthalate (SBFI) for evaluation of various compounds on epileptiform activities induced by 4-aminopyridine (4-AP) in cultured rat hippocampal neurons. Among the K+-channel openers, the KV7.2/KV7.3-channel openers retigabine and flupirtine and KCa2-channel openers NS309, DCEBIO, and 1-EBIO showed potent anti-epileptic effects similar to conventional antiepileptic drugs (AEDs). In contrast, the KCa1.1-channel openers NS1619, isopimaric acid, and chlorzoxazone demonstrated moderate inhibition. The Kir6-channel openers minoxidil, cromakalim, and pinacidil did not show anti-epileptic effects. We concluded that KV7.2/KV7.3, KCa2, and, to some extent, KCa1.1-channel openers, but not Kir6-channel openers, suppress 4-AP–induced epileptiform activities in hippocampal neurons. These results suggest that the K+-channel openers for this category of K+channels might have therapeutic potential as new classes of antiepileptic drugs. Keywords:: K+ channel, epilepsy, 4-aminopyridine (4-AP), hippocampal neuron, sodium-binding benzofuran isophthalate (SBFI) |
